Why Stryker Stock May Be Headed For A Prolonged Slowdown - Stryker ( NYSE:SYK )
Stryker Corporation ( NYSE:SYK ) is currently in Phase 8 of its 18-phase Adhishthana cycle on the weekly charts, and the stock has just broken its Cakra formation. This is a major bearish development within the framework and suggests a prolonged period of underperformance.
9 Robotics Stocks to Buy Before the Automation Wave Peaks
Labor shortages and the rise of AI are converging to make the adoption of robotics increasingly inevitable.
J&J's MedTech Unit Sales Improve: Will the Momentum Last?
J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.
Cardiac Arrest Treatment Market Set for Remarkable Growth Driven by Advanced Emergency Care and Rising Cardiac Cases: Verified Market Research®
Lewes, Delaware, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Cardiac Arrest Treatment Market Size projected to grow at a CAGR of 4.50% from 2024 to 2031, according to a new report published by Verified Market Research®.
ISRG Stock Gains More than 28% in a Month: Should You Buy, Hold or Sell?
Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.
All You Need to Know About Stryker ( SYK ) Rating Upgrade to Buy
Stryker (SYK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Stryker ( NYSE:SYK )
Stryker ( NYSE:SYK ) has outperformed the market over the past 10 years by 1.33% on an annualized basis producing an average annual return of 13.82%. Currently, Stryker has a market capitalization of $135.97 billion.
SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up
Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.
Abner Herrman & Brock Sours on Intuitive Surgical
Abner Herrman & Brock LLC ( AHB ) reduced its stake in Intuitive Surgical ( NASDAQ:ISRG ) by almost 10,000 shares, worth over $4.5 million, during the quarter ended September 30, 2025.According to its October 14, 2025 SEC filing, Abner Herrman & Brock trimmed its position in Intuitive Surgical ( ...
Stryker ( SYK ) Q3 Earnings and Revenues Beat Estimates
Stryker (SYK) delivered earnings and revenue surprises of +1.59% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
What Analyst Projections for Key Metrics Reveal About Stryker ( SYK ) Q3 Earnings
Beyond analysts' top-and-bottom-line estimates for Stryker (SYK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?
Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.
Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.
The Zacks Analyst Blog Highlights Moodys, Stryker and CBRE
Zacks highlights three wide-moat leaders Moody's, Stryker, and CBRE poised to deliver durable returns through strong fundamentals, innovation, and strategic expansion.
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4
MCO, SYK and CBRE stand out as wide moat stocks with strong growth forecasts and strategic expansions to boost portfolio resilience.
Will ISRG's dV5 Lend Momentum to Top Line During Q3 Earnings?
Intuitive Surgical's new da Vinci 5 is driving strong hospital upgrades and premium pricing, setting up ISRG for potential top-line momentum in Q3.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. SYK, NVDA, RMD and RL hold promise.
Price Over Earnings Overview: Stryker - Stryker ( NYSE:SYK )
In the current session, Stryker Inc. ( NYSE:SYK ) is trading at $369.25, after a 0.14% decrease. Over the past month, the stock fell by 2.27%, and in the past year, by 0.08%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...
J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan
J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.
New Jersey Rep. Thomas Kean Sold Up to $215K Worth of Franklin Resources Stock - Check Point Software ( NASDAQ:CHKP ) , Franklin Resources ( NYSE:BEN )
A report on October 14, 2025 shows that Representative Thomas Kean from New Jersey sale stock in Franklin Resources ( NYSE:BEN ) , valued between $61,005 and $215,000. According to the October filing, the transaction occurred on September 3, 2025.
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
If You Invested $100 In Stryker Stock 20 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )
Stryker ( NYSE:SYK ) has outperformed the market over the past 20 years by 2.6% on an annualized basis producing an average annual return of 11.62%. Currently, Stryker has a market capitalization of $139.83 billion.
Is J&J's MedTech Segment Set for Another Quarter of Growth?
J&J's MedTech sales are gaining traction in Cardiovascular, Surgery, and Vision, even as China???s VBP program continues to weigh on growth.
P/E Ratio Insights for Stryker - Stryker ( NYSE:SYK )
Looking into the current session, Stryker Inc. ( NYSE:SYK ) shares are trading at $374.29, after a 0.27% drop. Over the past month, the stock fell by 3.73%, but over the past year, it actually increased by 5.26%.
SNN or SYK: Which Is the Better Value Stock Right Now?
SNN vs. SYK: Which Stock Is the Better Value Option?
Looking Into Stryker Corp's Recent Short Interest - Stryker ( NYSE:SYK )
Stryker Corp's ( NYSE:SYK ) short interest as a percent of float has risen 10.43% since its last report. According to exchange reported data, there are now 4.61 million shares sold short, which is 1.27% of all regular shares that are available for trading.
1 Reason I'm Watching Intuitive Surgical Stock in 2026
The surgical robotics pioneer could cement its leading position for years to come.
If You Invested $100 In Stryker Stock 10 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )
Stryker ( NYSE:SYK ) has outperformed the market over the past 10 years by 1.53% on an annualized basis producing an average annual return of 14.3%. Currently, Stryker has a market capitalization of $141.42 billion.
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
ISRG SP Platform's Expansion in Korea and Europe Gains Traction
Intuitive Surgical's SP platform gains momentum with 112% growth in Korea and steady European uptake, highlighting global adoption despite regional headwinds.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
SNN vs. SYK: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew ( SNN Quick QuoteSNN - ) and Stryker ( SYK Quick QuoteSYK - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 14.52%. Currently, Stryker has a market capitalization of $146.02 billion.
SNN or SYK: Which Is the Better Value Stock Right Now?
SNN vs. SYK: Which Stock Is the Better Value Option?
Investing in the Age of Longevity: Silver Economy Stocks in Focus
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
Has Akero Therapeutics ( AKRO ) Outpaced Other Medical Stocks This Year?
Here is how Akero Therapeutics, Inc. (AKRO) and Stryker (SYK) have performed compared to their sector so far this year.
Stryker's Robotics and Global Gains Offset by Macro Concerns
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Stryker ( SYK ) Upgraded to Buy: What Does It Mean for the Stock?
Stryker (SYK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 1.86% on an annualized basis producing an average annual return of 14.02%. Currently, Stryker has a market capitalization of $145.32 billion.
SNN vs. SYK: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew ( SNN Quick QuoteSNN - ) and Stryker ( SYK Quick QuoteSYK - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise.
J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?
Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.
This Is What Whales Are Betting On Stryker - Stryker ( NYSE:SYK )
Whales with a lot of money to spend have taken a noticeably bullish stance on Stryker. Looking at options history for Stryker SYK we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 12% ...
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
BALTIMORE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appointment of Tim Scannell, former President & COO of Stryker Corporation, as Chair of its Board of ...
Stryker ( SYK ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 31, 2025, at 4:30 p.m. ETFor a direct quote from a Motley Fool analyst, please email [email protected] reading ...
Are Medical Stocks Lagging Stryker ( SYK ) This Year?
Here is how Stryker (SYK) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
